MC
CVET

Moors & Cabot’s Covetrus, Inc. Common Stock CVET Stock Holding History

Moors & Cabot’s Portfolio CVET Stock Details CVET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-20,500
Closed -$270K – 702
2019
Q4 		$270K Buy
+20,500
New +$248K 0.03% 488

Other funds holding CVET

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Freshford Capital Management Rye Brook, New York $200M AUM 31.49% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Moors & Cabot's CVET Position: Q1 2020 in Review

Moors & Cabot sold out of Covetrus, Inc. Common Stock (CVET) in Q1 2020, closing a stake of 20,500 shares — an estimated $270K sold.

Moors & Cabot first reported a position in CVET in Q4 2019 and held it in 1 quarter. The position peaked at $270K in Q4 2019. 249 funds tracked by Wall St. Rank hold CVET as of Q1 2020.

  • Moors & Cabot reported no remaining Covetrus, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Moors & Cabot sold 20,500 Covetrus, Inc. Common Stock shares in Q1 2020, an estimated $270K.
  • Moors & Cabot first reported a position in Covetrus, Inc. Common Stock in Q4 2019 and held it in 1 quarter.
  • Moors & Cabot's Covetrus, Inc. Common Stock position peaked at $270K in Q4 2019.
  • 249 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q1 2020.

Based on Moors & Cabot's 13F filing for Q1 2020, filed 12 May 2020.